pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·May 6·1 min read
save

Color Health expands into cancer treatment coordination with virtual tumor boards

May 6, 2026·read at STAT ↗Positive

Color Health, a telehealth firm that currently coordinates cancer screening, is moving into providing and coordinating actual cancer care services.

CEO Othman Laraki says the growing complexity of cancer treatment and the rapid increase in patients are outpacing the supply of oncologists, prompting a shift toward virtual, AI‑driven solutions. He predicts that major cancer centers will adopt a virtual‑first model in the coming years.

The company has earned ASCO certification for its patient‑care navigation platform and is launching virtual tumor boards to help clinicians manage treatment pathways, aiming to streamline care and curb rising costs.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: Color Health moving deeper into cancer services, complete with virtual ‘tumor boards’”

read at STAT ↗
581 words · retrieved May 6
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
LILLYNOVONovo Nordisk IncRISING
drugs
OzempicWegovyWegovy Pill
topics
Oncology27HepatologyImmunologyMonoclonal Antibody

related stories

  • May 6STAT+: Novo Nordisk’s less-bad news on its Wegovy pill boosts earnings and share priceSTAT
  • Sep 22Novo targets 10-fold jump in oral Wegovy manufacturing capacity by 2030BioSpace
  • Sep 21Novo struggles to appease restive investors with consumer plans, blockbuster ambitionsFierce Biotech
  • Sep 9Webinar: The Massive Scale of GLP-1s: Evolving Health, Healthcare and MarketsBioSpace
  • Aug 28STAT+: Pharmalittle: We’re reading about an AstraZeneca trial failure, a ‘monstrous’ conflict of interest, and moreSTAT